Search

Author/Creator Goadsby, Peter J

3. Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial. (October 2019)

Authors:
Diener, Hans-Christoph; Goadsby, Peter J; Ashina, Messoud; Al-Karagholi, Mohammad Al-Mahdi; Sinclair, Alexandra; Mitsikostas, Dimos; Magis, Delphine; Pozo-Rosich, Patricia; Irimia Sieira, Pablo; Làinez, Miguel JA; Gaul, Charly; Silver, Nicholas; Hoffmann, Jan; Marin, Juana; Liebler, Eric; Ferrari...
Journal:
Cephalalgia
Issue:
Volume 39:Number 12(2019)
Page Start:
1475
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial. Issue 10200 (31st August 2019)

Authors:
Croop, Robert; Goadsby, Peter J; Stock, David A; Conway, Charles M; Forshaw, Micaela; Stock, Elyse G; Coric, Vladimir; Lipton, Richard B
Journal:
Lancet
Issue:
Volume 394:Issue 10200(2019)
Page Start:
737
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine. (October 2019)

Authors:
Ashina, Messoud; Goadsby, Peter J; Reuter, Uwe; Silberstein, Stephen; Dodick, David; Rippon, Gregory A; Klatt, Jan; Xue, Fei; Chia, Victoria; Zhang, Feng; Cheng, Sunfa; Mikol, Daniel D
Journal:
Cephalalgia
Issue:
Volume 39:Number 11(2019)
Page Start:
1455
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults. (December 2019)

Authors:
Goadsby, Peter J; Tepper, Stewart J; Watkins, Paul B; Ayele, Girma; Miceli, Rosa; Butler, Matthew; Severt, Lawrence; Finnegan, Michelle; Szegedi, Armin; Trugman, Joel M; Jakate, Abhijeet
Journal:
Cephalalgia
Issue:
Volume 39:Number 14(2019)
Page Start:
1753
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment. (August 2020)

Authors:
Dodick, David W; Goadsby, Peter J; Lucas, Christian; Jensen, Rigmor; Bardos, Jennifer N; Martinez, James M; Zhou, Chunmei; Aurora, Sheena K; Yang, Jyun Yan; Conley, Robert R; Oakes, Tina
Journal:
Cephalalgia
Issue:
Volume 40:Number 9(2020)
Page Start:
935
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Co-activation of rhythms during alpha band oscillations as an interictal biomarker of exploding head syndrome. (August 2020)

Authors:
Fotis Sakellariou, Dimitris; Nesbitt, Alexander David; Higgins, Sean; Beniczky, Sandor; Rosenzweig, Jan; Drakatos, Panagis; Gildeh, Nadia; Murphy, Patrick Brian; Kent, Brian; Williams, Adrian John; Kryger, Meir; Goadsby, Peter J; Leschziner, Guy Doron; Rosenzweig, Ivana
Journal:
Cephalalgia
Issue:
Volume 40:Number 9(2020)
Page Start:
949
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗